(Q44778688)

6 December 2017

title

Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates (English)

1 reference

6 December 2017

0 references

1 reference

7

Kiat Ruxrungtham

1 reference

6 December 2017

Chutitorn Ketloy

1

1 reference

6 December 2017

Anneke Engering

2

1 reference

6 December 2017

Utaiwan Srichairatanakul

3

1 reference

6 December 2017

Amporn Limsalakpetch

4

1 reference

6 December 2017

Kosol Yongvanitchit

5

1 reference

6 December 2017

Sathit Pichyangkul

6

1 reference

6 December 2017

publication date

8 May 2008

1 reference

Veterinary Immunology and Immunopathology

6 December 2017

published in

1 reference

6 December 2017

volume

125

1 reference

6 December 2017

issue

1-2

1 reference

6 December 2017

page(s)

18-30

1 reference

Toll-like receptors: critical proteins linking innate and acquired immunity

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Immunobiology of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

The immune response modifier resiquimod mimics CD40-induced B cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Characterization of virus-responsive plasmacytoid dendritic cells in the rhesus macaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Interferon-producing cells: on the front line in immune responses against pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

A Toll-like receptor recognizes bacterial DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Non-human primate models for AIDS vaccine research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Toll-like receptor control of the adaptive immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Use of CpG oligodeoxynucleotides as immune adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

CpG motifs: the active ingredient in bacterial extracts?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Modulating vaccine responses with dendritic cells and Toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

CpG oligodeoxynucleotides as vaccine adjuvants in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Regulation of Toll-like receptors in human monocytes and dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

The use of non-human primates as animal models for the study of hepatitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.05.001

10.1016/J.VETIMM.2008.05.001

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference